Surface Oncology Inc. (SURF)
NASDAQ: SURF
· Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM
Surface Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 30M | n/a | n/a | 30M | 154K | 392K | 515K | 1.63M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | 30M | n/a | n/a | 30M | 154K | 392K | 515K | 1.63M |
Operating Income | -25.64M | -19.66M | -21.18M | -22.9M | -24.62M | 6.84M | -23.37M | -19.49M | -18.59M | -14.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -28.19M | -19.74M | -21.33M | -23.24M | -25.21M | 6.2M | -24.05M | -19.89M | -18.98M | -15.56M |
Net Income | -28.19M | -20.75M | -21.48M | -23.58M | -25.8M | 6.2M | -24.05M | -19.89M | -18.98M | -15.56M |
Selling & General & Admin | 8.58M | 5.89M | 5.9M | 6M | 6.43M | 6.54M | 7.21M | 5.85M | 6.43M | 5.64M |
Research & Development | 13.83M | 13.78M | 15.29M | 16.89M | 18.2M | 16.62M | 16.32M | 14.04M | 12.67M | 10.54M |
Other Expenses | n/a | n/a | n/a | n/a | 144K | 45K | 7K | 20K | 23K | 22K |
Operating Expenses | 22.41M | 19.66M | 21.18M | 22.9M | 24.62M | 23.16M | 23.53M | 19.88M | 19.1M | 16.18M |
Interest Expense | 3.11M | 932K | 149K | 829K | 733K | 682K | 676K | 421K | 416K | 1.02M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.41M | 19.66M | 21.18M | 22.9M | 24.62M | 23.16M | 23.53M | 19.88M | 19.1M | 16.18M |
Income Tax Expense | n/a | 1.01M | 149K | 342K | 589K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.72M | 60.63M | 60.56M | 59.05M | 54.65M | 48.61M | 46.44M | 45.24M | 43.63M | 41.62M |
Shares Outstanding (Diluted) | 60.72M | 60.63M | 60.56M | 59.05M | 54.65M | 49.82M | 46.44M | 45.24M | 43.63M | 41.62M |
EPS (Basic) | -0.46 | -0.34 | -0.35 | -0.4 | -0.47 | 0.12 | -0.52 | -0.44 | -0.44 | -0.37 |
EPS (Diluted) | -0.46 | -0.34 | -0.35 | -0.4 | -0.47 | 0.12 | -0.52 | -0.44 | -0.44 | -0.37 |
EBITDA | -25.64M | -18.49M | -29.07M | -22.07M | -24.13M | 7.23M | -23.37M | -19.08M | -18.17M | -14.13M |
EBIT | -25.08M | -18.81M | n/a | -22.41M | -24.48M | 6.88M | n/a | -19.47M | -18.57M | -14.54M |
Depreciation & Amortization | 1.99M | 1.17M | 331K | 833K | 490K | 345K | 375K | 392K | 396K | 406K |